CVS Group plc CVSGF
16.60 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
17.22 Day range 17.22
14.50 52-week range 17.22
- YTD
- +2.34%
- 1 year
- +0.12%
- Market cap
- 1.11B
- EPS (ttm)
- 0.33
- P/E ratio
- 50.30
- YTD return
- +2.34%
- 1-year return
- +0.12%
- Volume
- 100
- Avg volume
- 10
- Open
- 17.22
- Previous close
- 16.60
- Day's range
- 17.22 – 17.22
- 52-week range
- 14.50 – 17.22
- Earnings date
- Sep 24, 2026
YTD +0.38 (+2.34%)
Next earnings
Sep 24, 2026
Expected Sep 24, 2026. Consensus EPS estimate 0.615.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Sep 24, 2026 | Jun 30, 2026 | 0.615 | — | — | — |
| Feb 26, 2026 | Dec 31, 2025 | 0.585 | 0.542 | -0.04 | -7.35% |
| Oct 7, 2025 | Jun 30, 2025 | 0.556 | 0.2905 | -0.27 | -47.75% |
| Feb 26, 2025 | Dec 31, 2024 | 0.512 | 0.1953 | -0.32 | -61.86% |
| Sep 26, 2024 | Jun 30, 2024 | 0.542 | -0.14822 | -0.69 | -127.35% |
| Mar 19, 2024 | Dec 31, 2023 | 0.598 | 0.2576 | -0.34 | -56.92% |
News
CVS Group plc (CVSGF) Q4 2026 Earnings Call Transcript 
CVS Group plc (CVSGF) Q4 2026 Earnings Call Transcript 
CVS Group plc (CVSGF) Q4 2026 Earnings Call Prepared Remarks Transcript 
CVS Group plc (CVSGF) Discusses Capital Investments in Facilities, Clinical Equipment and Technology to Drive Returns Transcript 
CVS Group Q4 Earnings Call Highlights 
Converium Capital Sends Letter to CVS Group Board Highlighting Company's Undervaluation and Urging £100 Million Share Buyback 
UK's CVS Group CEO to step down after 7 years at the helm 
CVS Group plc (CVSGF) Shareholder/Analyst Call Transcript 
CVS Group plc (CVSGF) Q2 2026 Earnings Call Prepared Remarks Transcript 
UK's CVS Group plans Main Market move, approves near $27 million buyback
Your note
Sign in to keep a note on CVSGF — it syncs with the Stock Master app.